CLINICAL_TRIALS
trial_result
· 2022-11-30
Clinical Trial Update: Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy [Phase 3]
Summary
Phase 3 trial updating efficacy and safety of DWP450 for benign masseteric hypertrophy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Benign Masseteric Hypertrophy | Phase 3 | Status: COMPLETED